The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial.

Abstract

The efficacy of secobarbital sodium plus chlorpromazine (SC) in the prevention of cisplatin induced emesis was compared to the combination of metoclopramide, diphenhydramine, and dexamethasone (MDD). Twenty-three patients were entered onto protocol. Eighteen were evaluable. Good to excellent antiemetic prophylaxis was obtained in 72% with MDD versus 17% with SC (P less than 0.01). Sedation and anticholinergic side effects were more common with SC. Extrapyramidal reactions were more commonly seen with MDD. Significantly more patients preferred the combination of metoclopramide, diphenhydramine, and dexamethasone (P less than 0.05).

• Authors: P D Richards, M A Flaum, M Bateman, C G Kardinal
• Journal: Cancer (Cancer) Vol. 58 Issue 4 Pg. 959-62 (Aug 15 1986) ISSN: 0008-543X [Print] United States
• PMID: 3521843 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Secobarbital
• Dexamethasone
• Diphenhydramine
• Metoclopramide
• Cisplatin
• Chlorpromazine

Topics

• Adult
• Chlorpromazine (adverse effects, therapeutic use)
• Cisplatin (adverse effects)
• Clinical Trials as Topic
• Dexamethasone (adverse effects, therapeutic use)
• Diphenhydramine (adverse effects, therapeutic use)
• Drug Administration Schedule
• Female
• Humans
• Male
• Metoclopramide (adverse effects, therapeutic use)
• Middle Aged
• Random Allocation
• Secobarbital (adverse effects, therapeutic use)
• Vomiting (chemically induced, prevention & control)